Advocating Change: One Synthetic Cannabinoid at a Time
Zofia talks about how compliance aspects associated with sample management are becoming more critical due to the collaborative and globally distributed nature of research. She showcases it through her experience working with the industry and authorities to modify the Third Generation Synthetic Cannabinoids amendment.
World’s Largest Protein-Ligand Complex and Binding Affinity Dataset for Data Driven Methods in Drug Design
Arun uncovers a collaborative, multi-phase research project involving Intel, AWS, Insilico Medicine and IIITH with the ultimate aim of creating the world’s largest protein-ligand complex and binding affinity dataset that significantly accelerates drug research and discovery timelines.
Are reaction data FAIR … and what can we do with that?
Gerd talks about how chemical reaction data needs to comply with FAIR principles in order to be reliable, reproductible, and be used for accurate AI/ML predictions. He addresses the specific challenges related to in-house chemical reaction data capturing and discuss what steps should be taken to make these databases more consistent for precise predictions.